Quantcast

Industry news that matters to you.  Learn more

Archives for July 2014

VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis

VigeneTech, Inc, in collaboration with BioLegend, Inc., today announced the release of LEGENDplex(TM) Data Analysis Software, an OEM software solution for analysis of multiplex data from flow cytometers. BioLegend develops and offers varieties of bead-based multi-analyte immunoassay products for use with flow cytometers. With the support of VigeneTech’s data analysis software, FCS data files can be automatically and accurately analyzed and easily reported.

Truven Health Analytics Links Clinical Data with Claims to Enhance Oncology Outcomes Research

Truven Health Analytics recently announced it has successfully linked electronic medical records (EMR) and administrative claims data with significant volume to power oncology-focused outcomes research studies. This de-identified data set, the newest addition to the MarketScan® research databases, provides a unique ability for researchers to better understand total healthcare costs, co-morbidities, adverse events, and outcomes for cancer patients by treatment phase, biomarker status, and tumor stage.

Restore Launches Pharmacogenetic Testing

Restore Health, a leading personalized medicine company that provides specialty and compounded pharmaceuticals, announced that it is now offering pharmacogenetic testing that provides drug sensitivity information unique to each individual based upon their particular genetic makeup. Comprehensive medication management is now possible by understanding the interaction between a patient’s genetics and their entire drug regimen.

New Mass Spectrometric Immunoassay Consumables Enable Large Biomolecule Analysis

Scientists at the forefront of proteomics research can achieve exceptional accuracy and speed using an expanded family of affinity-based consumables for large molecule bioanalysis. The new functionalized pipette tips feature proprietary microcolumn technology designed to enable enhanced, reproducible target purification and reduce complexity in biological samples prior to liquid chromatography-mass spectrometry (LC-MS) protocols.

Smell And Eye Tests Show Potential To Detect Alzheimer’s Early

A decreased ability to identify odors might indicate the development of cognitive impairment and Alzheimer’s disease, while examinations of the eye could indicate the build-up of beta-amyloid, a protein associated with Alzheimer’s, in the brain, according to the results of four research trials reported recently at the Alzheimer’s Association International Conference® 2014 (AAIC® 2014) in Copenhagen.